Gregor Diagnostics Inc.


BiotechProfiles™ is the premier resource for jobs, company information, professional networking and productivity tools in the Madison, Wisconsin biotechnology and medical device industry. Recognized as one of the premier emerging biotechnology clusters in the U.S., this robust industry sector comprises nearly 10,000 employees in approximately 150 companies. BiotechProfiles also maintains a unique directory of the largest 250 pharmaceutical companies worldwide, including business development contacts whenever available. This tool is indispensable for executives pursuing strategic alliances and technology licenses.
Designed as a suite of easy to use, searchable databases that are continually updated, BiotechProfiles serves the needs of biotech business development and operational executives in early stage companies, as well as the general public. With these tools you can quickly bypass the data collection and screening stage and immediately focus on solving your strategic partnering or operational needs. We've assembled your background data for you!
  Next »

BiotechProfiles is also the premier site for data on Biotechnology Companies in Madison Wisconsin, Biotechnology Jobs in Madison Wisconsin

Biotechnology Companies in Madison Wisconsin; Biotechnology Jobs in Madison Wisconsin
  « Previous | Next »

Biotechnology Business Development, Partnering and Strategic Alliances

Biotechnology Business Development, Partnering and Strategic Alliances
  « Previous | Next »

Madison Biotechnology Companies; Madison Biotechnology Jobs

Madison Biotechnology Companies; Madison Biotechnology Jobs
  « Previous | Next »

List or rank of Largest Pharmaceutical Companies Worldwide

List of rank of Largest Pharmaceutical Companies Worldwide
  « Previous


Company Profile

Gregor Diagnostics is a molecular diagnostics company developing a revolutionary new screening test for prostate cancer. Gregor’s patient-friendly test will be the first diagnostic to detect prostate cancer at the earliest stages of the disease and differentiate between indolent and aggressive cancer upon detection. This will result in decreased overdiagnosis and overtreatment of indolent prostate cancer, and more effective detection of aggressive prostate cancer.

The test is being based on prostate cancer biomarkers discovered at the the University of Wisconsin. Gregor has finalized exclusive terms of a license option agreement that will maintain the exclusivity while we negotiate the final licence terms.

Seminal fluid has a very distinct biological advantage in that 30% is produced directly by the prostate. This allows for biomarkers of early stage cancers to be at detectable limits in seminal fluid whereas they would not be detectable in blood. Several studies by academic institutions have demonstrated prostate cancer biomarkers are present in seminal fluid, but with limited sample sizes and biomarker panels.
Business Sectors
Pharmaceuticals   Human Diagnostics
Med or Lab Devices   Lab Reagents or Services  
Drug Manufacturing   Food & Agribusiness  
CRO   Bioinformatics or Software  
Company History
Gregor Diagnostics Inc.
Address 316 W. Washington Avenue, Suite 675
[Map] Madison
Website Link
Head Tobias Zutz, MS - Biotech
Company Statistics
Global Headcount 1
Local Headcount 1
Year Founded 2016
Ownership Private
Stock Exchange

Parent Company
Divisional Level
Senior Level
Global Headcount
Stock Exchange
Reference Documents
2018 - Gregor Adds $900,000 Investment [View]